NUR2102 Chronic Care Across the Life Span B

Running head: NUR2102 CHRONIC CARE ACROSS THE LIFE SPAN B
NUR2102 CHRONIC CARE ACROSS THE LIFE SPAN B
Name of the Student:
Name of the University:
Author Note:

NUR2102 CHRONIC CARE ACROSS THE LIFE SPAN B1
Considering the situation of the patient
The case study is about Viktor, who is a 63 years old man suffering from chronic
obstructive pulmonary disease (COPD). He had smoked about 20 cigarettes per day for
40years. He had been discharged from the hospital following a left lobe Pneumonia. His
medical infections history includes hypertension. He also suffers from sleep apnoea causing
an acute exacerbation of COPD.
Collect cues
It is evident from the case study that current medication of Victor includes-
 Trelegy Ellipta 100/25/62.5 micrograms 1 puff / day mane.
 PRN Salbutamol 200 μg in hard with spacer
 Augmentin duo fort 875/125 mg BD
 Prednisone 50 mg daily for five days mane
 Nicorette patches 15 mg/16 hours daily mane
 He is on home oxygen 2 L per minute for 18 hours per day via nasal prongs
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death
worldwide. In order to ease the burden and optimize the management of diseases and the
outcome, the self-management of the disease has the gained relevance in clinical practice
(Kaptein, Fischer & Scharloo, 2014). In self-management, the patient learns the necessary
skill required to cope with the symptoms.
Hence, the clinical priority chosen for Victor regarding his medication management is
that Victor should continue taking his medicines like Trelegy Ellipta , that is exclusively
needed for reducing the respiratory distress, that Victor suffers through during the COPD
episodes. Trelegy Ellipta is an anticholinergic and is used as a bronchodilator that works by

NUR2102 CHRONIC CARE ACROSS THE LIFE SPAN B2
relaxing the muscles (Abukwaik, Mansukhani & Bridgeman, 2018). Relaxation of the
muscles would allow people having difficulty in breathing to breathe better. They are used
for the treatment of COPD. Victor needs to take these medicines as it is seen that Victor
suffers from severe episodes of apnoea.
Another clinical priority for victor is to continue the using the transdermal patch, that is
used as a part of the Nicotine replacement therapy and it helps a patient to cope up with
withdrawal symptom faced by the chain smokers (Koegelenberg et al., 2014). Victor should
also continue to take his medicines controlling hypertension.
Individuals with chronic obstructive diseases are at a high risk of developing
cardiovascular disease. Restriction of the airways is a predictor risk of hypertension. COPD
which is now understood to be an association between the inflammation and sympathetic
over activity has also been reported (Imaizumi, Eguchi & Kario, 2014). Hence, it is necessary
that the patient continues the medications for hypertension.
Augmentin duo forte have probably been used for treating bacterial infection like
Pneumonia. It has been already been stated that Victor had been admitted with Pneumonia.
Pneumonia is strongly linked to Pneumonia as the mucosal surface of the COPD patients are
constantly exposed to microbial pathogens that can have the potential to cause pneumonia in
the susceptible hosts (Restrepo, Sibila & Anzueto, 2018). Hence, this medication needs to be
continued to prevent the recurrence of the infections.
Prednisone is a glucocorticoid medicines that is mainly used for supressing the
immune system and decrease the inflammation that is caused in the conditions like COPD.
Since, this medicine is an immunosuppressant, careful attention needs to be given, in case
any side effect occurs.